Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 11, 1998

View Archived Issues

Mutant Trypanosome Holds Clues For Sleeping Sickness Drugs

Elan Raises US$50M To Fund Alzheimer's Programs

British Biotech Shares Fall On Delay Of Zacutex Review

First Medical DNA Diagnostic Start-Up Launched In Germany

EU-Backed Gene Analysis Of Model Plant Nearing Finish

StressGen Licenses Patents For Stress Protein Expression

UK Biotech Investment Firm Recorded Drop In Portfolio

Cerep Reactivates Its Offering On France's Noveau Marché

Shiloov Raises $10M To Fund Diagnostics, End Legal Dispute

Transgene, Schering-Plough Deal A First For French Firm

Other News to Note

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.